• Inhibits HR DNA repair and disrupts DNA damage induced RAD51 foci formation.• Sensitizes osteosarcoma, cervical, and breast cancer cells to MMC by triggering synthetic lethality. IC50 = 20-40 μM. Here, RAD51 is linked to breast carcinoma.